Literature DB >> 2981496

Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation.

D J Winston, E S Huang, M J Miller, C H Lin, W G Ho, R P Gale, R E Champlin.   

Abstract

Restriction endonuclease analysis of purified viral DNA was used to study the molecular epidemiologic characteristics of cytomegalovirus infection in 18 patients having bone marrow transplantation. Four patients who had had asymptomatic excretion of cytomegalovirus in urine before transplantation subsequently developed a cytomegalovirus infection after transplantation (pneumonia in 2 patients, fever and viremia in 1 patient, and asymptomatic viruria in 1 patient). In each patient, the infection that developed after transplantation was caused by a cytomegalovirus strain genetically identical to the isolate detected in urine before transplantation. Cytomegalovirus isolates from different sites (buffy coat, lung, and urine) of the same patient were also identical, but cytomegalovirus isolates from different patients were never identical. Our results suggest that some cytomegalovirus infections after bone marrow transplantation may be caused by strains present before transplantation. The great structural and genetic variability of cytomegalovirus isolates must be considered in the development of effective diagnostic and immunoprophylactic measures for infection after marrow transplantation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981496     DOI: 10.7326/0003-4819-102-1-16

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  16 in total

Review 1.  Methods for subtyping and molecular comparison of human viral genomes.

Authors:  M Arens
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Risk factors for viral reactivation following bone marrow transplantation.

Authors:  D Pillay; A Webster; H G Prentice; P D Griffiths
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

3.  Rapid epidemiologic analysis of cytomegalovirus by using polymerase chain reaction amplification of the L-S junction region.

Authors:  D M Sokol; G J Demmler; G J Buffone
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

4.  Antigen-specific T-lymphocyte function after cord blood transplantation.

Authors:  Geoff Cohen; Shelly L Carter; Kenneth I Weinberg; Bernadette Masinsin; Eva Guinan; Joanne Kurtzberg; John E Wagner; Nancy A Kernan; Robertson Parkman
Journal:  Biol Blood Marrow Transplant       Date:  2006-12       Impact factor: 5.742

Review 5.  Molecular biology of cytomegalovirus.

Authors:  V C Emery; P D Griffiths
Journal:  Int J Exp Pathol       Date:  1990-12       Impact factor: 1.925

Review 6.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

7.  Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantation.

Authors:  T Schmeiser; W Heit; R Arnold; D Bunjes; M Wiesneth; B Hertenstein; W Hampl; H Heimpel
Journal:  Klin Wochenschr       Date:  1987-10-15

8.  Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease.

Authors:  P C Woo; C Y Lo; S K Lo; H Siau; J S Peiris; S S Wong; W K Luk; T M Chan; W W Lim; K Y Yuen
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

Review 9.  CMV-specific immune reconstitution following allogeneic stem cell transplantation.

Authors:  Emily Blyth; Barbara Withers; Leighton Clancy; David Gottlieb
Journal:  Virulence       Date:  2016-08-09       Impact factor: 5.882

10.  Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrow.

Authors:  T Schmeiser; M Wiesneth; D Bunjes; R Arnold; B Hertenstein; W Heit; E Kurrle
Journal:  Infection       Date:  1989 May-Jun       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.